G01N2333/8107 - CPC Classification Index

ClassID:

170533 ⎘

G01N2333/8107 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Protease inhibitors Endopeptidase (E.C. 3.4.21-99) inhibitors

Sub-classes:

G01N2333/811 » Serine protease (E.C. 3.4.21) inhibitors 52
G01N2333/8139 » Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin 76
G01N2333/8142 » Aspartate protease (E.C. 3.4.23) inhibitors, e.g. HIV protease inhibitors 9
G01N2333/8146 » Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP 90

Recent Application in this class:

20240011107

LIVE CELL ASSAY FOR PROTEASE INHIBITION

20220411874

METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS

20200319207

TREATING SCHIZOPHRENIA BASED ON A PANEL OF BIOMARKERS

20180265924

Methods for diagnosing and evaluating non-alcoholic steatohepatitis

20170023577

METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH PROTEASOME INHIBITION THERAPY

20160097779

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

20160018412

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

20150275163

Microfluidic device and leucocyte antigen mediated microfluidic assay

20150031561

BIOMARKER PANELS, DIAGNOSTIC METHODS AND TEST KITS FOR OVARIAN CANCER

20140200151

Treating schizophrenia based on a panel of biomarkers

20130345073

USE OF ALPHA-2-MACROGLOBULIN FOR DETERMINING OSTEONECROSIS DISEASE STATUS AND FOR SCREENING THERAPEUTIC AGENTS FOR PREVENTING OR TREATING OSTEONECROSIS

20130210041

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

20110229922

SCREENING ASSAYS FOR THE IDENTIFICATION OF BACE2 INHIBITORS

20110152341

CLEAVAGE OF B-AMYLOID PRECURSOR PROTEIN

20090181393

Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy

20090011451

Microfluidic device and leucocyte antigen mediated microfluidic assay

20080312420

Monoclonal antibodies for detection of urinary trypsin inhibitors

20070161120

Ceruloplasmin Assay

20070020683

Monoclonal antibodies for detection of urinary trypsin inhibitors

20060121540

Use of protein MASP as a marker for colorectal cancer

20060084057

Methods of diagnosing liver fibrosis